These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27139168)

  • 21. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
    Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
    Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
    Marie I; Hatron PY; Cherin P; Hachulla E; Diot E; Vittecoq O; Menard JF; Jouen F; Dominique S
    Arthritis Res Ther; 2013 Oct; 15(5):R149. PubMed ID: 24286268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffuse infiltrating lung disease secondary to antisynthetase syndrome: a case report].
    Moussa N; Khemakhem R; Snoussi M; Fekih W; Bahloul Z; Kammoun S
    Pan Afr Med J; 2021; 39():30. PubMed ID: 34394821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
    Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
    Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL; Lin WC; Yeh CC; Sun YT
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antisynthetase syndrome: a report of four cases and literature review].
    Frikha F; Saidi N; Snoussi M; Ben Salah R; Ben Ayed M; Daoud E; Hentati Y; Makni S; Mnif Z; Boudawara T; Masmoudi H; Bahloul Z
    Rev Pneumol Clin; 2012 Dec; 68(6):351-60. PubMed ID: 23062471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).
    Mejía M; Herrera-Bringas D; Pérez-Román DI; Rivero H; Mateos-Toledo H; Castorena-García P; Figueroa JE; Rojas-Serrano J
    Respir Med; 2017 Feb; 123():79-86. PubMed ID: 28137500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myositis-associated interstitial lung disease.
    Vu TTT; Brown KK; Solomon JJ
    Curr Opin Pulm Med; 2023 Sep; 29(5):427-435. PubMed ID: 37435671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients.
    Lefèvre G; Meyer A; Launay D; Machelart I; DeBandt M; Michaud J; Tournadre A; Godmer P; Kahn JE; Behra-Marsac A; Timsit MA; Schleinitz N; Wendling D; Melac-Ducamp S; Boyer P; Peretz A; Lequerré T; Richez C; Stervinou-Wemeau L; Morell-Dubois S; Lambert M; Dubucquoi S; Wallaert B; Benveniste O; Flipo RM; Hatron PY; Sibilia J; Hachulla E; Hervier B;
    Rheumatology (Oxford); 2015 May; 54(5):927-32. PubMed ID: 25349440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA;
    Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
    Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
    Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease.
    D'Cruz D; Keser G; Khamashta MA; Direskeneli H; Targoff IN; Miller F; Hughes GR
    J Rheumatol; 2000 Jan; 27(1):161-4. PubMed ID: 10648033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
    Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
    Respir Med; 2020; 165():105920. PubMed ID: 32174452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics of patients with antisynthetase syndrome and interstitial pulmonary disease].
    Li W; Li J; Xie WM; Ren YH; Dai HP
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1861-1865. PubMed ID: 32575928
    [No Abstract]   [Full Text] [Related]  

  • 38. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
    Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
    Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.
    Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD
    Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
    Labirua A; Lundberg IE
    Curr Opin Rheumatol; 2010 Nov; 22(6):633-8. PubMed ID: 20827201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.